menu
    • menu

    Company profile for Kyowa Kirin

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Kyowa Kirin is an R&D-based life sciences company with special strengths in biotechnology. The Kyowa Kirin Group companies strive to contribute to the health and well-being of people around the world by creating new value through the pursuit of advances in life sciences and technologies.We are opening up the path toward the development of new biologics, and developing new medicines to meet medical needs that are currently not ...
    Kyowa Kirin is an R&D-based life sciences company with special strengths in biotechnology. The Kyowa Kirin Group companies strive to contribute to the health and well-being of people around the world by creating new value through the pursuit of advances in life sciences and technologies.We are opening up the path toward the development of new biologics, and developing new medicines to meet medical needs that are currently not being satisfied by existing pharmaceuticals.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Kyowa Kirinjapan Flag
    Country
    Country
    Japan
    Address
    Address
    Ohtemachi Building, 1-6-1 Ohtemachi,
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.kyowa-kirin.com
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    KOMZIFTI™ (Ziftomenib) Included In (NCCN) Guidelines For AML
    KOMZIFTI™ (Ziftomenib) Included In (NCCN) Guidelines For AML

    25 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/25/3194795/35186/en/KOMZIFTI-ziftomenib-Added-to-National-Comprehensive-Cancer-Network-NCCN-Guidelines-for-Acute-Myeloid-Leukemia-AML.html

    GLOBENEWSWIRE
    25 Nov 2025
    Share Share
    Kura Oncology & Kirin Announce FDA Approval of Komzifti
    Kura Oncology & Kirin Announce FDA Approval of Komzifti

    13 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/13/3187609/35186/en/Kura-Oncology-and-Kyowa-Kirin-Announce-FDA-Approval-of-KOMZIFTI-ziftomenib-the-First-and-Only-Once-Daily-Targeted-Therapy-for-Adults-with-Relapsed-or-Refractory-NPM1-Mutated-Acute-.html

    GLOBENEWSWIRE
    13 Nov 2025
    Share Share
    Ultragenyx Sells Future Crysvita Royalties For $400 Million
    Ultragenyx Sells Future Crysvita Royalties For $400 Million

    04 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/04/3180804/20739/en/Ultragenyx-Announces-Sale-of-a-Portion-of-Future-North-American-Royalties-on-Crysvita-burosumab-for-400-Million-to-OMERS-Life-Sciences.html

    GLOBENEWSWIRE
    04 Nov 2025
    Share Share
    Kura Oncology Gets Second $30M Payment For AML Menin Inhibitor
    Kura Oncology Gets Second $30M Payment For AML Menin Inhibitor

    03 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/03/3179767/35186/en/Kura-Oncology-Receives-Second-30-Million-Development-Milestone-Payment-in-AML-Menin-Inhibitor-Program-With-Kyowa-Kirin.html

    GLOBENEWSWIRE
    03 Nov 2025
    Share Share
    Kura Oncology, Kyowa Kirin To Present Ziftomenib Ven/Aza Data
    Kura Oncology, Kyowa Kirin To Present Ziftomenib Ven/Aza Data

    03 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/03/3179417/35186/en/Kura-Oncology-and-Kyowa-Kirin-Announce-Presentations-of-Ziftomenib-Ven-Aza-Combination-Data-in-Frontline-and-Relapsed-Refractory-NPM1-m-or-KMT2A-r-Acute-Myeloid-Leukemia-at-2025-AS.html

    GLOBENEWSWIRE
    03 Nov 2025
    Share Share
    Kyowa Kirin Announces Appointment of Julie Dehaene-Puype
    Kyowa Kirin Announces Appointment of Julie Dehaene-Puype

    03 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251103040183/en/Kyowa-Kirin-International-Announces-Appointment-of-Julie-Dehaene-Puype-as-President-for-the-Region

    BUSINESSWIRE
    03 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Contact Kyowa Kirin and get a quotation

    Kyowa Kirin is a supplier offers 7 products (APIs, Excipients or Intermediates).

    Find a price of 7-Hydroxystaurosporine bulk offered by Kyowa Kirin

    Find a price of Istradefylline bulk offered by Kyowa Kirin

    Find a price of Olopatadine Hydrochloride bulk offered by Kyowa Kirin

    Find a price of RGI-2001 bulk offered by Kyowa Kirin

    Find a price of Spicamycin Analog bulk offered by Kyowa Kirin

    Find a price of KW-6356 DRUG SUBSTANCE bulk offered by Kyowa Kirin

    Find a price of ASKP1240 MONOCLONAL ANTIBODY DRUG SUBSTANCE AND DRUG PRODUCT bulk offered by Kyowa Kirin

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search